Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A

FEBS J. 2005 Nov;272(21):5572-83. doi: 10.1111/j.1742-4658.2005.04952.x.

Abstract

The natriuretic peptide receptor-A (NPR-A) is composed of an extracellular ligand-binding domain, a transmembrane-spanning domain, a kinase homology domain (KHD) and a guanylyl cyclase domain. Because the presence of ATP or adenylylimidodiphosphate reduces atrial natriuretic peptide (ANP) binding and is required for maximal guanylyl cyclase activity, a direct interaction of ATP with the receptor KHD domain is plausible. Therefore, we investigated whether ATP interacts directly with a binding site on the receptor by analyzing the binding of a photoaffinity analog of ATP to membranes from human embryonic kidney 293 cells expressing the NPR-A receptor lacking the guanylyl cyclase moiety (DeltaGC). We demonstrate that this receptor (NPR-A-DeltaGC) can be directly labeled by 8-azido-3'-biotinyl-ATP and that labeling is highly increased following ANP treatment. The mutant receptor DeltaKC, which does not contain the KHD, is not labeled. Photoaffinity labeling of the NPR-A-DeltaGC is reduced by 50% in the presence of 550 microm ATP, and competition curve fitting studies indicate a Hill slope of 2.2, suggestive of cooperative binding. This approach demonstrates directly that the interaction of ANP with its receptor modulates the binding of ATP to the KHD, probably through a conformational change in the KHD. In turn, this conformational change is essential for maximal activity. In addition, the ATP analog, 8-azido-adenylylimidodiphosphate, inhibits guanylyl cyclase activity but increases ANP binding to the extracellular domain. These results suggest that the KHD regulates ANP binding and guanylyl cyclase activity independently.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / chemistry
  • Adenosine Triphosphate / metabolism*
  • Adenosine Triphosphate / pharmacology
  • Atrial Natriuretic Factor / metabolism
  • Atrial Natriuretic Factor / pharmacology*
  • Binding Sites
  • Biotin / analogs & derivatives
  • Biotin / chemistry
  • Biotin / metabolism
  • Biotin / pharmacology
  • Cell Line
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Guanylate Cyclase / antagonists & inhibitors
  • Guanylate Cyclase / chemistry*
  • Guanylate Cyclase / metabolism*
  • Humans
  • Protein Binding / drug effects
  • Receptors, Atrial Natriuretic Factor / antagonists & inhibitors
  • Receptors, Atrial Natriuretic Factor / chemistry*
  • Receptors, Atrial Natriuretic Factor / metabolism*

Substances

  • 8-N(3)-3'-biotinyl-ATP
  • Enzyme Inhibitors
  • Biotin
  • Atrial Natriuretic Factor
  • Adenosine Triphosphate
  • Guanylate Cyclase
  • Receptors, Atrial Natriuretic Factor
  • atrial natriuretic factor receptor A